MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery.

Phase 2
Completed
Conditions
Anemia
Blood Transfusion
Orthopedic Procedures
First Posted Date
2005-12-26
Last Posted Date
2011-05-18
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
1
Registration Number
NCT00270036

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Phase 3
Completed
Conditions
Carcinoma, Small Cell Lung
Anemia
Multiple Myeloma
Esophagus Cancer
Neoplasm
Lymphoma
Ovarian Cancer
Breast Cancer
Prostate Cancer
First Posted Date
2005-12-26
Last Posted Date
2011-05-18
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
201
Registration Number
NCT00270166

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

Phase 2
Completed
Conditions
Anemia
Acquired Immunodeficiency Syndrome
First Posted Date
2005-12-26
Last Posted Date
2011-05-18
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
60
Registration Number
NCT00269945

A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery.

Phase 3
Completed
Conditions
Anemia
Blood Transfusion
Orthopedic Procedures
First Posted Date
2005-12-26
Last Posted Date
2011-05-18
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
316
Registration Number
NCT00270088

Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia

Phase 2
Completed
Conditions
Anemia
Leukemia, Lymphocytic, Chronic
Leukemia, Lymphocytic
Cancer
Neoplasms
Quality of Life
First Posted Date
2005-12-26
Last Posted Date
2011-05-18
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
195
Registration Number
NCT00270049

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee.

Phase 3
Completed
Conditions
Anemia
Blood Transfusions, Autologous
Orthopedic Procedures
First Posted Date
2005-12-26
Last Posted Date
2011-05-18
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
17
Registration Number
NCT00270140

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

Phase 3
Completed
Conditions
Anemia
Cancer
Neoplasm
First Posted Date
2005-12-26
Last Posted Date
2011-05-18
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
375
Registration Number
NCT00270127
© Copyright 2025. All Rights Reserved by MedPath